State Lotteries Didn’t Help Boost Vaccination Rates

Written by Stephen Rheinberg HealthDay reporter FRIDAY, Oct. 15, 2021 (HealthDay News) — The $1 million winning shot has done nothing to change the number of people who have taken the COVID-19 hit. According to a new study, lotteries in 19 states designed to encourage people to receive the COVID-19 vaccination did not change the … Read more

Gut Bacteria May Fuel Prostate Cancer Treatment Resistance

Oct 15, 2021 – A mainstay of prostate cancer treatment is to deprive it of androgens, the hormones that make it grow. The testicles are the main source of these hormones, so treatment can consist of either surgical removal of these organs or the use of medications to block the production of hormones. Over time, … Read more

Supercomputers Mimic Brain Activity, Hunt for COVID Treatments

Oct 15, 2021 – Machine learning has come a long way in the quarter century since the computer nicknamed Deep Blue shocked the world by defeating chess champion Garry Kasparov. Today, when our smartphones have far more computing power than Deep Blue, scientists have set their sights on even greater adversaries, including killer diseases like … Read more

$100 Million Investment Aims to Ease Health Worker Shortage

Written by Robert Pridet and Robin FosterHealthDay reporter FRIDAY, Oct. 15, 2021 (HealthDay News) — The White House announced Thursday that the National Health Service will receive $100 million to help address the shortage of health care workers in the United States. That’s a fivefold increase in funding over previous years for a program that … Read more

Breast Cancer 2021: Much Progress, But Work Remains

Much progress has been made in the fight against breast cancer, but much work remains. Here’s what experts say should happen next. .

Merck to Ask FDA for Emergency Approval of Its New Antiviral Pill for COVID

Robin Foster, HealthDay reporter FRIDAY, Oct 1, 2021 (HealthDay News) — Pharmaceutical giant Merck & Co said Friday it will seek federal approval for emergency use of its new antiviral pill molonopiravir, after a clinical trial showed the drug cut the risk of hospitalization in half. . Death when administered to high-risk individuals shortly after … Read more

Colon Cancer Diagnoses Fell 40% in Pandemic, and That’s Not Good News

Written by Kara MorrisHealthDay reporter MONDAY, Oct 4, 2021 (HealthDay News) — Colon cancer numbers have dropped dramatically during the COVID-19 pandemic, but that doesn’t mean fewer people are getting sick. In Spain, researchers discovered a 40% reduction in colon cancer diagnoses, leading experts to worry about the repercussions. The lead author, Dr. Maria Jose … Read more